Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DENN domain-containing protein 11 (DENND11) is a probable guanine nucleotide exchange factor (GEF), potentially involved in promoting the exchange of GDP to GTP, thereby activating small GTPase proteins[7][6][1]. It belongs to the DENND11 protein family, but its precise biological roles, interacting partners, and disease relevance remain poorly characterized[2][3][4]. DENND11 is expressed in various tissues, including the brain, but current data do not support its status as a therapeutic target, nor are there any approved or experimental drugs targeting this protein[3][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DENN domain-containing protein 11 (DENND11).